STEPHEN B.H. KENT, PH.D.

Corporate Board Profile

Tech Score: 100/100

← Back to All Directors

Software Technology Evidence

3 mention(s) identify STEPHEN B.H. KENT, PH.D. as having software/technology expertise.

Company Filing Date Evidence Reason
ENZO BIOCHEM INC 2008-11-28 Dr. Kent is or has been a Professor of Biochemistry & Molecular Biology (2001-present), Professor of Chemistry (2002-present). Dr. Kent is a Professor of Biochemistry & Molecular Biology and has a strong academic background in science, indicating technical skills.
ENZO BIOCHEM INC 2011-11-28 Dr. Kent is or has been a Professor of Biochemistry & Molecular Biology and Professor of Chemistry at the University of Chicago. Dr. Kent has a strong academic background in biochemistry and molecular biology, and has served as a director of biotech companies, indicating potential technical skills.
ENZO BIOCHEM INC 2012-11-27 Dr. Kent is or has been a Professor of Biochemistry & Molecular Biology at the University of Chicago. Dr. Kent has a strong academic background in biochemistry and molecular biology, and has been involved in biotechnology companies, indicating familiarity with technical concepts, though not explicitly programming.

ENZO BIOCHEM INC

Filing Date Source Excerpt
2008-11-28 Dr. Kent is or has been a Professor of Biochemistry & Molecular Biology (2001-present), Professor of Chemistry (2002-present).
2011-11-28 Dr. Kent is or has been a Professor of Biochemistry & Molecular Biology and Professor of Chemistry at the University of Chicago.
2012-11-27 Dr. Kent is or has been a Professor of Biochemistry & Molecular Biology at the University of Chicago.

Data sourced from SEC filings. Last updated: 2025-07-01